ArticleMolecular cancer therapeutics2026

JNJ-79032421, a Novel Membrane-Restricted Mesothelin-Targeting T Cell-Engaging Bispecific Antibody for the Treatment of Mesothelin-Positive Cancers.

Karine Smans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.